Apolipoprotein B correlates with intra-plaque necrotic core volume in stable coronary artery disease

Takayuki Ohwada1, Takayuki Sakamoto1, Yuki Kanno2

  • 1Fukushima Red Cross Hospital, Department of Cardiology, Fukushima City, Japan.

Plos One
|February 20, 2019
PubMed

Insights

High apolipoprotein B (Apo-B) levels correlate with increased necrotic core (NC) in coronary artery lesions of stable coronary artery disease (SCD) patients. This suggests Apo-B may indicate unstable plaque in this population.

Area of Science:

  • Cardiovascular Medicine
  • Biomarkers
  • Medical Imaging

Background:

  • Coronary artery disease (CAD) plaque composition is crucial for cardiovascular events.
  • Lipid profiles, including low-density lipoprotein cholesterol (LDL-C) and apolipoprotein B (Apo-B), are key risk factors.
  • Virtual histology intravascular ultrasound (VH-IVUS) allows detailed plaque characterization.

Purpose of the Study:

  • To investigate the association between specific lipid markers and coronary plaque composition.
  • To determine if Apo-B levels correlate with vulnerable plaque features, specifically necrotic core (NC) volume.
  • To explore the utility of Apo-B as a biomarker for unstable plaque in stable coronary artery disease (SCD) patients.

Main Methods:

  • VH-IVUS was used to quantify plaque components (fibrous, fibrofatty, necrotic core, dense calcium) in 115 SCD patients undergoing percutaneous coronary intervention (PCI).
  • Plasma levels of LDL-C, high-density lipoprotein cholesterol (HDL-C), Apo-B, and Apo-A1 were measured prior to PCI.
  • Patients were stratified into low Apo-B (LAB) and high Apo-B (HAB) groups based on the median Apo-B level.

Main Results:

  • Patients in the HAB group exhibited significantly greater vessel, plaque, and %NC volumes compared to the LAB group.
  • A significant positive correlation was found between %NC volume and both LDL-C and Apo-B levels across all patients.
  • Multiple regression analysis identified male sex, Apo-A1, and Apo-B as significant predictors of %NC volume.

Conclusions:

  • Elevated Apo-B levels are associated with a higher necrotic core component in coronary artery lesions of SCD patients.
  • Apo-B may serve as a valuable biomarker for identifying unstable plaque characteristics in patients with stable coronary artery disease.
  • These findings highlight the role of lipid metabolism in modulating plaque vulnerability.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.1K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
420
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
249
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
364
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
663
The Nucleosome Core Particle02:10

The Nucleosome Core Particle

Nucleosomes are the DNA-histone complex, where the DNA strand is wound around the histone core. The histone core is an octamer containing two copies of H2A, H2B, H3, and H4 histone proteins.
The paradox
Nucleosomes, paradoxically, perform two opposite functions simultaneously. On the one hand, their main responsibility is to protect the delicate DNA strands from physical damage and help achieve a higher compaction ratio. While on the other hand, they must allow polymerase enzymes to access DNA...
14.4K